Navigation Links
Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
Date:3/17/2008

Company's two lead ophthalmology programs in development are now funded by our partners."

Diabetic retinopathy (DR), a complication of diabetes mellitus, is the leading cause of blindness in the working-age population of developed countries. At any time during progression of diabetic retinopathy, patients can develop DME, which involves retinal thickening of the macular area. In the United States, as many as 200,000 people are diagnosed with DME each year and an estimated 1,000,000 people suffer from DME. Currently there are no FDA approved drug treatments for DME.

About Alimera Sciences Inc.

Alimera Sciences Inc. is singularly focused on the development and commercialization of prescription ophthalmology pharmaceuticals. Founded by an executive team with extensive development and revenue growth expertise, Alimera Sciences' products are focused on improving the delivery of therapeutic agents to enhance patients' lives and strengthen physicians' ability to manage ocular conditions.

Alimera completed enrollment in October 2007 of its 956-patient Phase III clinical trial of fluocinolone acetonide in the Medidur(TM) drug delivery system for the treatment of diabetic macular edema. Alimera has also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment for ophthalmic diseases. The agreement gives Alimera the exclusive option to license compounds which are NADPH (nicotinamide adenine dinucleotide phosphate reduced form) oxidase inhibitors as potential treatments for conditions such as the dry form of age-related macular degeneration (AMD), particularly the late stage of this condition known as geographic atrophy. Alimera retains the right to use the Medidur delivery system for two of these compounds.

About pSivida Limited

pSivida is a global drug delivery company committed to the biomedical sect
'/>"/>

SOURCE Alimera Sciences
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
2. Pressure BioSciences, Inc. to Discuss 2007 Financial Results and Provide Business Update
3. DARA BioSciences, Inc. Announces Appointment of New Director to Board
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
5. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
6. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
7. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
8. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
9. Pressure BioSciences, Inc. Provides Corporate Update
10. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Researchers from the National Institute of Standards and Technology ... new way to introduce magnetic impurities in a semiconductor ... (STM). Detailed in a recent paper,* this technique will ... one at a time to learn about its electrical ...
(Date:12/4/2009)... Micro Nano Technology Products (ACAMP) hosts, ... 4 /PRNewswire/ - Today ACAMP hosted a health ... biomaterials and microfluidics can play a powerful role ... help promote health and improve the quality, cost ...
(Date:12/4/2009)... Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused ... of ethanol from non-food cellulosic wastes, has been ranked number ... "50 Hottest Companies in Bioenergy;" the company,s second consecutive year ... Ethanol among the top 20 bioenergy companies for two straight ...
(Date:12/3/2009)... MELVILLE, N.Y., Dec. 3 Nikon Corporation, an ... it has signed a licensing agreement with Harvard ... Stochastic Optical Reconstruction Microscopy (STORM) technology. Under the ... enabled microscopy systems and market them with the ...
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Alberta companies delivering new products to the health & medical marketplace 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3
... - David Cagigal knows the missing link in many ... after the implementation. , ,Cagigal, chief information technology officer ... miscalculate return on investment often neglect to factor in ... cost over the life of the application. , , ...
... Milwaukee, Wis. - To meet a growing bioinformatics challenge, ... from the Medical College of Wisconsin and Children's ... worldwide genetic tracking of human and animal influenza viruses. ... and health officials since the onset of the avian or ...
... potential infringers by licensing the patent rather than going ... a recent Federal Circuit Court ruling, that could become ... do this by sending out a carefully worded letter ... license and then negotiating the terms. These unsolicited licensing ...
Other Biology Technology:The business case for software applications 2The business case for software applications 3Medical College team creates website for tracking flu 2Medical College team creates website for tracking flu 3Patent licensing: For enforcing companies, the rules have changed 2Patent licensing: For enforcing companies, the rules have changed 3
(Date:12/4/2009)... to an analysis of statewide data taken from 1998-2001, ... year were more than three times likely to report ... their insurance status during pregnancy and delivery. , ... times more likely among mothers with Medicaid coverage, and ...
(Date:12/4/2009)... new mathematical model of heart cells, University of Iowa ... calmodulin kinase II (CaM kinase), disrupts the electrical activity ... also involved Columbia University, was published online Dec. 3 ... , "Recently, researchers have developed great interest in calmodulin ...
(Date:12/3/2009)... species can be likened to emptying a museum of its ... the trash, or replacing every local cuisine with McDonald,s burgers. ... not just make the world boring. New research now suggests ... some nasty disease. , "Habitat destruction and biodiversity loss,"driven by ...
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2U-Iowa study helps advance heart-related research 2Species down, disease up 2Species down, disease up 3Species down, disease up 4National Patients Rights Advocate Joins Truman Medical Centers as General Counsel 50009 1National Patients Rights Advocate Joins Truman Medical Centers as General Counsel 50009 2World Nanomedicine Market to Cross 24160 Billion by 2015 According to New Report by Global Industry Analysts Inc 12778 1World Nanomedicine Market to Cross 24160 Billion by 2015 According to New Report by Global Industry Analysts Inc 12778 2World Nanomedicine Market to Cross 24160 Billion by 2015 According to New Report by Global Industry Analysts Inc 12778 3iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 1iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 2iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 3iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 4
... This press release is not and,must not be, ... Japan, South Africa or the United States of America. ... jurisdictions or elsewhere,where their participation requires further offer documents, ... Swedish law. This is a,translation of the original Swedish ...
... researchers led by MIT has explained how contaminated batches ... traditional safety screens and kill dozens of patients recently ... led by Professor Ram Sasisekharan of MIT, identified the ... sulfate (OSCS). The researchers present their findings and offer ...
... oral health could become the first tool for dental ... disease treatments, say researchers at the University of Michigan. ... the bug that makes it is Porphyromonas gingivalis, an ... potential as a vaccine candidate, according to Charles Shelburne, ...
Other Biology News:Oberthur Technologies XPon Offer 2MIT-led teams unravel heparin death mystery 2MIT-led teams unravel heparin death mystery 3Presence of certain antibodies signals healthier teeth and gums 2
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Biology Products: